169 related articles for article (PubMed ID: 11300027)
1. [Capecitabine in the treatment of colorectal cancer].
Zeuli M; Pino MS; Cognetti F
Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027
[No Abstract] [Full Text] [Related]
2. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
3. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
4. [Capecitabine in colorectal carcinoma: news from ASCO 2008]].
Longo F; Mansueto G
Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712
[No Abstract] [Full Text] [Related]
5. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.
Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064
[No Abstract] [Full Text] [Related]
6. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
8. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
[TBL] [Abstract][Full Text] [Related]
9. X-ACT: an important step on an unfinished journey.
Maughan T
Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
[No Abstract] [Full Text] [Related]
10. Capecitabine in the treatment of colorectal cancer.
O'Neill VJ; Cassidy J
Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
[TBL] [Abstract][Full Text] [Related]
12. [Doxifluridine for treatment of colorectal cancer].
Nishimura G; Miwa K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
[No Abstract] [Full Text] [Related]
13. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
14. [New therapeutic prospects with capecitabin in breast carcinoma].
Venturini M; Catzeddu T
Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671
[No Abstract] [Full Text] [Related]
15. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.
Van Cutsem E; Verslype C; Tejpar S
Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505
[TBL] [Abstract][Full Text] [Related]
16. On prejudice and facts and choices.
Köhne CH; Folprecht G
Ann Oncol; 2006 Feb; 17(2):185-7. PubMed ID: 16428244
[No Abstract] [Full Text] [Related]
17. Capecitabine in the treatment of colorectal cancer.
Kelly C; Cassidy J
Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine in the management of colorectal cancer.
Maroun JA
Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
[TBL] [Abstract][Full Text] [Related]
20. The role of capecitabine in the treatment of colorectal cancer in the elderly.
Pasetto LM; Monfardini S
Anticancer Res; 2006; 26(3B):2381-6. PubMed ID: 16821620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
